The kinetics and phenotype of the human B-cell response following immunization with a heptavalent pneumococcal-CRM197 conjugate vaccine

Immunology

Volumn 119, Issue 3, 2006, Pages 328-337

  Clutterbuck, Elizabeth A ^a   Salt, Penny ^a   Oh, Sarah ^a   Marchant, Arnaud ^b   Beverley, Peter ^c   Pollard, Andrew John ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^c EDWARD JENNER INST FOR VACC RES   (United Kingdom)

Author keywords

Antibody forming cells; B cell subsets; Conjugate vaccine; Memory B cells; Pneumococcal vaccine

Indexed keywords

BACTERIUM ANTIBODY; CD20 ANTIBODY; CD27 ANTIGEN; CD38 ANTIGEN; DIPHTHERIA TOXOID; GLYCOCONJUGATE; IMMUNOGLOBULIN G; INTERLEUKIN 2; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBODY PRODUCING CELL; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BACTERIAL STRAIN; FEMALE; HOST RESISTANCE; HUMAN; HUMAN EXPERIMENT; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOPHENOTYPING; IN VITRO STUDY; INFECTION RESISTANCE; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; MALE; MEMORY CELL; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PLASMA CELL; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; UNITED KINGDOM; VOLUNTEER;

ADULT; B-LYMPHOCYTE SUBSETS; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HUMANS; IMMUNIZATION, SECONDARY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOLOGIC MEMORY; IMMUNOPHENOTYPING; INTERLEUKIN-2; MALE; MENINGOCOCCAL VACCINES; PNEUMOCOCCAL VACCINES; STAPHYLOCOCCUS AUREUS; VACCINES, CONJUGATE;

EID: 33750030806     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2006.02436.x     Document Type: Article

References (51)

1. Fedson DS, Scott JA. The burden of pneumococcal disease among adults in developed and developing countries. what is and is not known. Vaccine 1999; 17 (Suppl. 1):S11-8.
2. Weller S, Braun MC, Tan BK et al. Human blood IgM 'memory' B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood 2004; 104:3647-54.
3. + T cell help. J Immunol 2004; 172:532-9.
4. Adderson EE. Antibody repertoires in infants and adults: effects of T-independent and T-dependent immunizations. Springer Semin Immunopathol 2001; 23:387-403.
5. Black S, Shinefield H, Baxter R, Austrian R, Bracken L, Hansen J, Lewis E, Fireman B. Postlicensure surveillance for pneumococcal invasive disease after use of heptavalent pneumococcal conjugate vaccine in Northern California Kaiser Permanente. Pediatr Infect Dis J 2004; 23:485-9.
6. Heath PT, Booy R, Azzopardi HJ et al. Antibody concentration and clinical protection after Hib conjugate vaccination in the United Kingdom. JAMA 2000; 284:2334-40.
7. Ramsay ME, McVernon J, Andrews NJ, Heath PT, Slack MP. Estimating Haemophilus influenzae type b vaccine effectiveness in England and Wales by use of the screening method. J Infect Dis 2003; 188:481-5.
8. Trotter CL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet 2004; 364:365-7.
9. Crotty S, Aubert RD, Glidewell J, Ahmed R. Tracking human antigen-specific memory B cells. a sensitive and generalized ELISPOT system. J Immunol Methods 2004; 286:111-22.
10. Concepcion N, Frasch CE. Evaluation of previously assigned antibody concentrations in pneumococcal polysaccharide reference serum; 89SF:by the method of cross-standardization. Clin Diagn Lab Immunol 1998; 5:199-204.
11. Wernette CM, Frasch CE, Madore D et al. Enzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharides. Clin Diagn Laboratory Immunol 2003; 10:514-9.
12. Heilmann C, Henrichsen J, Pedersen FK. Vaccination-induced circulation of human B cells secreting type-specific antibodies against pneumococcal polysaccharides. Scand J Immunol 1987; 25:61-7.
13. Milligan GN, Fairchild RL, Sterner KE, Braley-Mullen H. Type 6 and 19 pneumococcal polysaccharides coupled to erythrocytes elicit pneumococcal cell wall-specific primary IgM responses and capsular polysaccharide-specific secondary IgG responses. Eur J Immunol 1990; 20:595-603.
14. Kehrl JH, Fauci AS. Characterization of the cellular immune response following in vivo immunization with pneumococcal polysaccharides in man. Bull Eur Physiopathol Respir 1983; 19:227-34.
15. Brokstad KA, Cox RJ, Olofsson J, Jonsson R, Haaheim LR. Parenteral influenza vaccination induces a rapid systemic and local immune response. J Infect Dis 1995; 171:198-203.
16. Falkoff RJ, Zhu LP, Fauci AS. The relationship between immunization and circulating antigen-specific plaque-forming cells. Cell Immunol 1983; 78:392-9.
17. Nieminen T, Kayhty H, Virolainen A, Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine 1998; 16:313-9.
18. Odendahl M, Mei H, Hoyer BF et al. Generation of migratory antigen-specific plasma blasts and mobilisation of resident plasma cells in a secondary immune response. Blood 2005; 105:1614-21.
19. Hasbold J, Corcoran LM, Tarlinton DM, Tangye SG, Hodgkin PD. Evidence from the generation of immunoglobulin G-secreting cells that stochastic mechanisms regulate lymphocyte differentiation. Nat Immunol 2004; 5:55-63.
20. Dilosa RM, Maeda K, Masuda A, Szakal AK, Tew JG. Germinal center B cells and antibody production in the bone marrow. J Immunol 1991; 146:4071-7.
21. McHeyzer-Williams LJ, McHeyzer-Williams MG. Antigen-specific memory B cell development. Annu Rev Immunol 2005; 23:487-513.
22. Suzuki N, Ueda Y, Sakane T. Differential mechanism for differentiation into immunoglobulin-secreting cells in human resting B lymphocyte subsets isolated on the basis of cell density. J Clin Invest 1988; 81:261-9.
23. Nanan R, Heinrich D, Frosch M, Kreth HW. Acute and long-term effects of booster immunisation on frequencies of antigen-specific memory B-lymphocytes. Vaccine 2001; 20:498-504.
24. Soenawan E, Srivastava I, Gupta S et al. Maintenance of long-term immunological memory by low avidity IgM-secreting cells in bone marrow after mucosal immunizations with cholera toxin adjuvant. Vaccine 2004; 22 (11-12):1553-63.
25. Cassese G, Arce S, Hauser AE et al. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J Immunol 2003; 171:1684-90.
26. + B lymphocyte subset. J Immunol 1992; 148:3700-5.
27. Nagumo H, Agematsu K, Kobayashi N et al. The different process of class switching and somatic hypermutation; a novel analysis by CD27 (-) naive B cells. Blood 2002; 99:567-75.
28. Saiki O, Ralph P. IgM- and IgD-bearing peripheral blood lymphocytes differentiate to IgM but not IgG or IgA immunoglobulin-secreting cells. Eur J Immunol 1982; 12:506-10.
29. Bernasconi NL, Traggiai E, Lanzavecchia A. Maintenance of serological memory by polyclonal activation of human memory B cells. Science 2002; 298:2199-202.
30. Dorner T, Radbruch A. Selecting B cells and plasma cells to memory. J Exp Med 2005; 201:497-9.
31. Kunkel EJ, Butcher EC. Plasma-cell homing. Nat Rev Immunol 2003; 3:822-9.
32. Gourley TS, Wherry EJ, Masopust D, Ahmed R. Generation and maintenance of immunological memory. Semin Immunol 2004; 16:323-33.
33. Manz RA, Hauser AE, Hiepe F, Radbruch A. Maintenance of serum antibody levels. Annu Rev Immunol 2005; 23:367-86.
34. Slifka MK, Ahmed R. Long-lived plasma cells: a mechanism for maintaining persistent antibody production. Curr Opin Immunol 1998; 10:252-8.
35. Zinkernagel RM, Hengartner H. On immunity against infections and vaccines: credo 2004. Scand J Immunol 2004; 60:9-13.
36. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG. Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 2003; 187:1424-32.
37. Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG. Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children. J Infect Dis 2004; 190:1203-11.
38. Hausdorff WP, Feikin DR, Klugman KP. Epidemiological differences among pneumococcal serotypes. Lancet Infect Dis 2005; 5:83-93.
39. Hausdorff WP, Yothers G, Dagan R et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002; 21:1008-16.
40. Jacquot S, Kobata T, Iwata S, Morimoto C, Schlossman SF. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses: enhancement of plasma cell differentiation by CD27 signaling. J Immunol 1997; 159:2652-7.
41. Joshua D, Pope B, Brown R, Brown L, Murray A, Gibson J. Phenotyping primitive plasma cells. Br J Haematol 2002; 117:252-3.
42. O'Connor BP, Gleeson MW, Noelle RJ, Erickson LD. The rise and fall of long-lived humoral immunity: terminal differentiation of plasma cells in health and disease. Immunol Rev 2003; 194:61-76.
43. Weller S, Faili A, Aoufouchi S, Gueranger Q, Braun M, Reynaud CA, Weill JC. Hypermutation in human B cells in vivo and in vitro. Ann N Y Acad Sci 2003; 987:158-65.
44. Oliver AM, Martin F, Kearney JF. IgMhigh CD21high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999; 162:7198-207.
45. +) human B cells. Eur J Immunol 2001; 31:243-9.
46. Weller S, Reynaud CA, Weill JC. Vaccination against encapsulated bacteria in humans: paradoxes. Trends Immunol 2005; 26:85-9.
47. Ekstrom N, Ahman H, Verho J, Jokinen J, Vakevainen M, Kilpi T, Kayhty H. Kinetics and avidity of antibodies evoked by heptavalent pneumococcal conjugate vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial. Infect Immun 2005; 73:369-77.
48. Huebner RE, Mbelle N, Forrest B, Madore DV, Klugman KP. Long-term antibody levels and booster responses in South African children immunized with nonavalent pneumococcal conjugate vaccine. Vaccine 2004; 22:2696-700.
49. Shinefield HR, Black S, Ray P et al. Safety and immunogenicity of heptavalent pneumococcal CRM197 conjugate vaccine in infants and toddlers. Pediatr Infect Dis J 1999; 18:757-63.
50. Mawas F, Feavers IM, Corbel MJ. Serotype of Streptococcus pneumoniae capsular polysaccharide can modify the Th1/Th2 cytokine profile and IgG subclass response to pneumococal-CRM (197) conjugate vaccines in a murine model. Vaccine 2000; 19:1159-66.
51. Kalka-Moll WM, Tzianabos AO, Bryant PW, Niemeyer M, Ploegh HL, Kasper DL. Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol 2002; 169:6149-53.